CAPTRUST Financial Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,697
| Closed | -$48K | – | 2254 |
|
|
2022
Q3 | $48K | Buy |
30,697
+28,504
| +1,300% | +$44.6K | ﹤0.01% | 1989 |
|
|
2022
Q2 | $4K | Sell |
2,193
-736
| -25% | -$1.34K | ﹤0.01% | 4248 |
|
|
2022
Q1 | $7K | Buy |
2,929
+736
| +34% | +$1.76K | ﹤0.01% | 4020 |
|
|
2021
Q4 | $10K | Sell |
2,193
-907
| -29% | -$4.14K | ﹤0.01% | 3739 |
|
|
2021
Q3 | $24K | Hold |
3,100
| – | – | ﹤0.01% | 3052 |
|
|
2021
Q2 | $30K | Buy |
3,100
+829
| +37% | +$8.02K | ﹤0.01% | 2845 |
|
|
2021
Q1 | $19K | Sell |
2,271
-6,016
| -73% | -$50.3K | ﹤0.01% | 3050 |
|
|
2020
Q4 | $57K | Buy |
8,287
+1,750
| +27% | +$12K | ﹤0.01% | 1775 |
|
|
2020
Q3 | $70K | Buy |
6,537
+4,887
| +296% | +$52.3K | ﹤0.01% | 1514 |
|
|
2020
Q2 | $11K | Buy |
+1,650
| New | +$11K | ﹤0.01% | 2155 |
|
|
2019
Q4 | – | Sell |
-2,000
| Closed | -$4K | – | 1938 |
|
|
2019
Q3 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 1711 |
|
|
2019
Q2 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 1666 |
|
|
2019
Q1 | $10K | Buy |
+2,000
| New | +$10K | ﹤0.01% | 1397 |
|